SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-17-000114
Filing Date
2017-10-04
Accepted
2017-10-04 16:47:39
Documents
8
Period of Report
2017-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k-crystalmerger8k.htm 8-K 57427
2 EXHIBIT 2.1 exhibit21-crystalmergeragr.htm EX-2.1 769213
3 EXHIBIT 99.1 ligandtoacquirecrystalbi.htm EX-99.1 17262
4 ligandtoacquirecrystalbi001.jpg GRAPHIC 182689
5 ligandtoacquirecrystalbi002.jpg GRAPHIC 192580
6 ligandtoacquirecrystalbi003.jpg GRAPHIC 215030
7 ligandtoacquirecrystalbi004.jpg GRAPHIC 273866
8 ligandtoacquirecrystalbi005.jpg GRAPHIC 4086
  Complete submission text file 0000886163-17-000114.txt   2037624
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 171122199
SIC: 2834 Pharmaceutical Preparations